Jennifer A. Ligibel, MD, senior physician in the Breast Oncology Center at Dana-Farber Cancer Institute, Boston, Massachusetts, talks with Lindsay L. Peterson, MD, MSCR, about results from the Breast Cancer Weight Loss (BWEL) Trial, which tested the efficacy of a weight loss intervention on metabolic and inflammatory biomarkers in women with obesity and breast cancer.